Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



TMBIM3/GRINA is a novel unfolded protein response (UPR) target gene that controls apoptosis through the modulation of ER calcium homeostasis
Indexado
WoS WOS:000303822800011
Scopus SCOPUS_ID:84860774401
DOI 10.1038/CDD.2011.189
Año 2012
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Transmembrane BAX inhibitor motif-containing (TMBIM)-6, also known as BAX-inhibitor 1 (BI-1), is an anti-apoptotic protein that belongs to a putative family of highly conserved and poorly characterized genes. Here we report the function of TMBIM3/GRINA in the control of cell death by endoplasmic reticulum (ER) stress. Tmbim3 mRNA levels are strongly upregulated in cellular and animal models of ER stress, controlled by the PERK signaling branch of the unfolded protein response. TMBIM3/GRINA synergies with TMBIM6/BI-1 in the modulation of ER calcium homeostasis and apoptosis, associated with physical interactions with inositol trisphosphate receptors. Loss-of-function studies in D. melanogaster demonstrated that TMBIM3/GRINA and TMBIM6/BI-1 have synergistic activities against ER stress in vivo. Similarly, manipulation of TMBIM3/GRINA levels in zebrafish embryos revealed an essential role in the control of apoptosis during neuronal development and in experimental models of ER stress. These findings suggest the existence of a conserved group of functionally related cell death regulators across species beyond the BCL-2 family of proteins operating at the ER membrane. Cell Death and Differentiation (2012) 19, 1013-1026; doi:10.1038/cdd.2011.189; published online 13 January 2012

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Cell Biology
Biochemistry & Molecular Biology
Scopus
Molecular Biology
Cell Biology
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Rojas-Rivera, D. Hombre Universidad de Chile - Chile
2 ARMISEN-YANEZ, RICARDO AMADO Hombre Universidad de Chile - Chile
3 COLOMBO-FLORES, ALICIA ANGELINA Mujer Universidad de Chile - Chile
4 MARTINEZ, -BRAVO, GABRIELA RAQUEL ELENA Mujer Universidad de Chile - Chile
5 Eguiguren, A. L. Mujer Universidad de Chile - Chile
6 DIAZ-CRUZ, ALEXIS RODRIGO Mujer Universidad de Chile - Chile
7 Kiviluoto, Santeri Hombre Katholieke Univ Leuven - Bélgica
KU Leuven - Bélgica
8 RODRIGUEZ-GONZALEZ, DIEGO ALEJANDRO Hombre Universidad de Chile - Chile
9 Patron, M. - Univ Padua - Italia
Natl Res Council CNR - Italia
Università degli Studi di Padova - Italia
10 Rizzuto, Rosario Hombre Univ Padua - Italia
Natl Res Council CNR - Italia
Università degli Studi di Padova - Italia
11 Bultynck, Geert Hombre Katholieke Univ Leuven - Bélgica
KU Leuven - Bélgica
12 CONCHA-NORDEMANN, MIGUEL LUIS Hombre Universidad de Chile - Chile
13 JARA-WILDE, J. Mujer Universidad de Chile - Chile
14 STUTZIN-SCHOTTLANDER, ANDRES JOAQUIN Hombre Universidad de Chile - Chile
15 HETZ-FLORES, CLAUDIO ANDRES Hombre Universidad de Chile - Chile
Harvard University - Estados Unidos
Harvard T.H. Chan School of Public Health - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Origen de Citas Identificadas



Muestra la distribución de países cuyos autores citan a la publicación consultada.

Citas identificadas: Las citas provienen de documentos incluidos en la base de datos de DATACIENCIA

Citas Identificadas: 17.46 %
Citas No-identificadas: 82.53999999999999 %

Muestra la distribución de instituciones nacionales o extranjeras cuyos autores citan a la publicación consultada.

Citas identificadas: Las citas provienen de documentos incluidos en la base de datos de DATACIENCIA

Citas Identificadas: 17.46 %
Citas No-identificadas: 82.53999999999999 %

Financiamiento



Fuente
FONDECYT
CONICYT
FONDAP
Fondo Nacional de Desarrollo Científico y Tecnológico
Comisión Nacional de Investigación Científica y Tecnológica
Millennium Nucleus
Howard Hughes Medical Institute
International Center for Genetic Engineering and Biotechnology
International Centre for Genetic Engineering and Biotechnology
Alzheimer's Association
Muscular Dystrophy Association
ICGEB
Comisión Nacional de Investigación Científica y Tecnológica
Seventh Framework Programme
Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica
Michael J Fox Foundation for Parkinson Research
Michael J. Fox Foundation for Parkinson's Research
Alzheimer’s Association
Millennium Initiative
North American Spine Society
INTNL

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
We apologize to all colleagues whose work could not be cited owing to space limitations. We thank David Ron for providing IRE1 alpha and PERK-deficient cells, Dr. Ann-Hwee Lee for providing and generating IRE1 alpha KO-reconstituted cells, and Dr. NirHacohen and the Broad Institute (Boston, MA, USA) for providing shRNA lentiviral constructs. We also thank Dr. John Reed for kindly providing bi-1<SUP>-/-</SUP> cells and Dr. Randal Kaufman for providing ATF6 alpha-deficient cells. We thank Peter Thielen for technical assistant in cloning. We thank Cecilia Zunigafor for his technical support with fluorescence-activated cell sorting analysis, Tomas Luyten for technical support with <SUP>45</SUP>Ca<SUP>2+</SUP>-flux assays and Jan Parys for helpful discussions. This work was supported by the FONDECYT no. 1100176, Alzheimer's Association, Muscular Dystrophy Association, Michael J Fox Foundation for Parkinson Research, North American Spine Society, and ICGEB (to CH); FONDECYT no. 1090272 (JS), FONDECYT no. 11090324(AC), Howard Hughes Medical Institute (INTNL 55005940), FONDECYT (1090242) and the Millennium Initiative (ICM P07-048-F) (MC); FONDECYT no. 3100033 (DR); CONICYT Doctoral fellowship (DR-R, GM); UCH-0606 (DR-R); CONICYT no. 24090143 (DR-R), Millennium Nucleus no. P07-048-F (CH, MC, JS); FONDAP Grant no. 15010006 (RA, AS and CH); Grants STRT1/10/044 (GB).
Acknowledgements. We apologize to all colleagues whose work could not be cited owing to space limitations. We thank David Ron for providing IRE1a and PERK-deficient cells, Dr. Ann-Hwee Lee for providing and generating IRE1a KO-reconstituted cells, and Dr. NirHacohen and the Broad Institute (Boston, MA, USA) for providing shRNA lentiviral constructs. We also thank Dr. John Reed for kindly providing bi-1−/−cells and Dr. Randal Kaufman for providing ATF6a-deficient cells. We thank Peter Thielen for technical assistant in cloning. We thank Cecilia Zuñigafor for his technical support with fluorescence-activated cell sorting analysis, Tomas Luyten for technical support with 45Ca2+-flux assays and Jan Parys for helpful discussions. This work was supported by the FONDECYT no. 1100176, Alzheimer’s Association, Muscular Dystrophy Association, Michael J Fox Foundation for Parkinson Research, North American Spine Society, and ICGEB (to CH); FONDECYT no.1090272 (JS), FONDECYT no. 11090324(AC), Howard Hughes Medical Institute (INTNL 55005940), FONDECYT (1090242) and the Millennium Initiative (ICM P07-048-F) (MC); FONDECYT no. 3100033 (DR); CONICYT Doctoral fellowship (DR-R, GM); UCH-0606 (DR-R); CONICYT no. 24090143 (DR-R), Millennium Nucleus no. P07-048-F (CH, MC, JS); FONDAP Grant no. 15010006 (RA, AS and CH); Grants STRT1/10/044 (GB).

Muestra la fuente de financiamiento declarada en la publicación.